Australia's most trusted
source of pharma news
Saturday, 27 April 2024
Posted 20 January 2022 PM
Pfizer's Paxlovid has beaten MSD's Lagevrio in the time it took to win provisional TGA approval for their oral Covid treatments by three months.
The TGA announced its approval for both drugs today (Thursday) - marking a new phase in the battle against COVID-19 as the first oral Covid treatments to become available in Australia.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.